Cargando…
Excitotoxicity: Still Hammering the Ischemic Brain in 2020
Interest in excitotoxicity expanded following its implication in the pathogenesis of ischemic brain injury in the 1980s, but waned subsequent to the failure of N-methyl-D-aspartate (NMDA) antagonists in high profile clinical stroke trials. Nonetheless there has been steady progress in elucidating un...
Autor principal: | Choi, Dennis W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649323/ https://www.ncbi.nlm.nih.gov/pubmed/33192266 http://dx.doi.org/10.3389/fnins.2020.579953 |
Ejemplares similares
-
Increased Susceptibility to Ischemic Brain Injury in Neuroplastin 65-Deficient Mice Likely via Glutamate Excitotoxicity
por: Hu, Yuhui, et al.
Publicado: (2017) -
Hammering Does Not Fit Fitts' Law
por: Petrič, Tadej, et al.
Publicado: (2017) -
Excitotoxicity therapy for stroke patients still alive
por: Domercq, Maria, et al.
Publicado: (2018) -
Hammer On
Publicado: (1860) -
Hammer on
Publicado: (1876)